Research map: Association of GLI1 overexpression with acanthomatous change in ameloblastoma

Back to the article

Papers in this map

  1. NIH Image to ImageJ: 25 years of image analysis · Caroline A Schneider · 2012 · 67294 citations · Cited by this paper
  2. Comparison of pain, anxiety, and oral health-related quality of life in orthodontic treatment using traditional, self-ligating, and clear aligner systems · 2025 · Related
  3. Identification of recurrent SMO and BRAF mutations in ameloblastomas · Robert T. Sweeney · 2014 · 368 citations · Cited by this paper
  4. A scientometric study on herbal medicine and identification of herbaceous agents for oral cancer prevention · 2026 · Related
  5. High frequency of BRAF V600E mutations in ameloblastoma · Kari J. Kurppa · 2013 · 312 citations · Cited by this paper
  6. Hidden pain: Diagnostic and management challenges of burning mouth syndrome · 2026 · Related
  7. Activating FGFR2–RAS–BRAF Mutations in Ameloblastoma · Noah A. Brown · 2014 · 306 citations · Cited by this paper
  8. In vitro characterization of tooth-derived and dentin-derived graft particles: Comparative analysis of particle size, mineral composition, and cytotoxicity · 2026 · Related
  9. Oncogenic KRAS Activates Hedgehog Signaling Pathway in Pancreatic Cancer Cells · Zhenyu Ji · 2007 · 295 citations · Cited by this paper
  10. Retrospective accuracy comparison of marker-based and marker-free registrations using dynamic implant navigation · 2025 · Related
  11. PTCH Gene Mutations in Odontogenic Keratocysts · D.C. Barreto · 2000 · 238 citations · Cited by this paper
  12. Cholesterol granuloma in the anterior maxilla–A case report · 2026 · Related
  13. Odontogenic tumors · Yong Lu · 1998 · 207 citations · Cited by this paper
  14. Gastric parietal cell and thyroid autoantibodies in patients with oral lichen planus · 2025 · Related
  15. Clinical and Radiographic Response With Combined BRAF-Targeted Therapy in Stage 4 Ameloblastoma · Frederic J. Kaye · 2014 · 141 citations · Cited by this paper
  16. 2-hydroxy ethylmethacrylate activates the extrinsic and intrinsic apoptotic processes through mitogen-activated protein kinase signaling pathways in cementoblasts - An in vitro study · 2026 · Related
  17. Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours · Marina Gonçalves Diniz · 2015 · 126 citations · Cited by this paper
  18. Graph neural network-based prediction of all-cause and cardiovascular mortality using periodontal site-level data from National Health and Nutrition Examination Survey (NHANES) · 2026 · Related
  19. Regulation of the hedgehog signaling by the mitogen‐activated protein kinase cascade in gastric cancer · Motoko Seto · 2009 · 122 citations · Cited by this paper
  20. Enhancing cone-beam computed tomography detail and interpretation with a generative adversarial network-driven artificial intelligence framework · 2025 · Related
  21. Early Dental Epithelial Transcription Factors Distinguish Ameloblastoma from Keratocystic Odontogenic Tumor · Kristiina Heikinheimo · 2014 · 108 citations · Cited by this paper
  22. BRAF inhibitor treatment of primary BRAF -mutant ameloblastoma with pathologic assessment of response · Serena Y. Tan · 2016 · 94 citations · Cited by this paper
  23. The landscape of genetic alterations in ameloblastomas relates to clinical features · Sibel Elif Gültekin · 2018 · 91 citations · Cited by this paper
  24. Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities? · Elisabetta Rovida · 2015 · 79 citations · Cited by this paper
  25. The immunoprofile of odontogenic keratocyst (keratocystic odontogenic tumor) that includes expression of PTCH, SMO, GLI‐1 and bcl‐2 is similar to ameloblastoma but different from odontogenic cysts · Marilena Vered · 2009 · 74 citations · Cited by this paper
  26. Durable treatment of ameloblastoma with single agent BRAFi Re: Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma · Daniel L. Faden · 2016 · 71 citations · Cited by this paper
  27. Odontogenic tumors in an African population · Adeyemi Mosadomi · 1975 · 70 citations · Cited by this paper
  28. Cross‐signaling among phosphinositide‐3 kinase, mitogen‐activated protein kinase and sonic hedgehog pathways exists in esophageal cancer · Lingyun Wei · 2010 · 61 citations · Cited by this paper
  29. High prevalence of BRAF V600E mutations in Korean patients with ameloblastoma: Clinicopathological significance and correlation with epithelial‐mesenchymal transition · Kyu‐Young Oh · 2019 · 43 citations · Cited by this paper
  30. GLI-mediated Keratin 17 expression promotes tumor cell growth through the anti-apoptotic function in oral squamous cell carcinomas · Yurie Mikami · 2017 · 42 citations · Cited by this paper
  31. Upfront rational therapy in BRAF V600E mutated pediatric ameloblastoma promotes ad integrum mandibular regeneration · Ariel Hirschhorn · 2021 · 41 citations · Cited by this paper
  32. Neoadjuvant BRAF-targeted therapy for ameloblastoma of the mandible: an organ preservation approach · Shirly Grynberg · 2023 · 38 citations · Cited by this paper
  33. An immunohistochemical and genetic study of BRAFV600E mutation in Japanese patients with ameloblastoma · Mai Seki · 2020 · 29 citations · Cited by this paper
  34. Calcifying epithelial odontogenic tumor: a case series spanning 25 years and review of the literature · Lauren A. Ruddocks · 2021 · 29 citations · Cited by this paper
  35. Enrichment of SOX2-Positive Cells in BRAF V600E Mutated and Recurrent Ameloblastoma · Chih‐Huang Tseng · 2022 · 19 citations · Cited by this paper
  36. Frequency of BRAF V600E mutation in a group of Thai patients with ameloblastomas · Puangwan Lapthanasupkul · 2020 · 18 citations · Cited by this paper
  37. Managing stage 4 ameloblastoma with dual BRAF/MEK inhibition: A case report with 8-year clinical follow-up · Zachary R. Abramson · 2022 · 17 citations · Cited by this paper
  38. Treatment of a BRAF V600E Positive Ameloblastoma in a Pediatric Patient with MEK Inhibitor Monotherapy · Steven Daws · 2021 · 9 citations · Cited by this paper
  39. Histopathologic and Molecular Insights Following the Management of Ameloblastomas via Targeted Therapies – Pathological and Clinical Perspectives · Ariel Hirschhorn · 2024 · 7 citations · Cited by this paper

Source: OpenAlex (CC0)